Sun Pharmaceutical Industries Share Price Today - Live Blog for March 26, 2025

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.62% decline, and it currently trades at ₹1,749.55 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.08% surge in its share price and is presently trading at ₹1,761.20. The increased investor interest is driving this surge.

With a -0.02% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,759.10. The stock is currently trading at a PE of 37.0600, while the industry PE is 34.7548, prompting investors to assess its value proposition.

Sun Pharmaceutical Industries Ltd witnessed a -0.05% decrease in its share price, and it is currently trading at ₹1,760.00. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 37.0600, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd experienced a -0.05% downturn in its share price, and it's currently trading at ₹1,760.50. This situation is generating interest among value investors who are evaluating the stock's potential.

After a notable 0.05% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,760.35. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0372 and an ROE of 15.9938%.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.05% increase and currently trading at ₹1,760.35 per share. Investors are taking notice of this upward momentum.

Sun Pharmaceutical Industries Ltd witnessed a -0.02% decrease in its share price, and it is currently trading at ₹1,759.45. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 37.0600, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.12% gain, with the share price now at ₹1,760.00. Notably, the stock's PE ratio stands at 37.0600, and its Return on Equity (ROE) is 15.9938%.

After a notable 0.24% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,759.85. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0372 and an ROE of 15.9938%.

Sun Pharmaceutical Industries Ltd's stock showed no movement, maintaining its position at ₹1,754.00. The stock has a PE ratio of 37.0600, an ROE of 15.9938%, and a debt to equity ratio of 0.0372.

The share price of Sun Pharmaceutical Industries Ltd remained fixed, with no fluctuations, and is currently at ₹1,754.00. Investors may choose to investigate the factors contributing to this price stability and whether it presents an investment opportunity.

Sun Pharmaceutical Industries Ltd witnessed a substantial 0.22% increase in its share price and is currently trading at ₹1,754.60. This remarkable performance has caught the eye of investors.

Sun Pharmaceutical Industries Ltd's shares saw an increase of 0.07%, reaching the current market price of ₹1,750.75. This development underscores the stock's growing popularity.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.10% in its share price, and it currently trades at ₹1,749.05 per share. The stock has an ROE of 15.9938% and debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd share price surged by 0.27%. With its current market price standing at ₹1,751.70 per share, this stock is garnering increased attention from the investment community.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.13% in its share price, and it currently trades at ₹1,747.70 per share. The stock has an ROE of 15.9938% and debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd has had quite the run lately, experiencing a substantial 0.28% uptick in its share price. As a result, it's now actively trading at ₹1,755.90 per share, making it an attractive option for investors.

Demonstrating a commendable 0.28% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,755.90. In terms of valuation, the stock maintains a PE ratio of 37.0600, while the industry PE ratio stands at 34.7548.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.23% drop, and it's now trading at ₹1,753.50 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Sun Pharmaceutical Industries Ltd shares saw a -0.23% decrease, reaching a current market price of ₹1,758.50. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 37.0600, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd witnessed a substantial 0.14% increase in its share price and is currently trading at ₹1,759.10. This remarkable performance has caught the eye of investors.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.12% uptick, and they are currently valued at ₹1,756.60, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0372 and an ROE of 15.9938%.

Sun Pharmaceutical Industries Ltd witnessed a -0.34% decrease in its share price, and it is currently trading at ₹1,754.80. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 37.0600, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.16%, a development that warrants careful analysis. Presently trading at ₹1,763.15, investors are assessing whether this presents an opportunity or a risk.